probenecid has been researched along with Toxoplasmosis in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Toxoplasmosis: The acquired form of infection by Toxoplasma gondii in animals and man.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Renschler, HE | 1 |
| Schumacher, K | 1 |
1 other study available for probenecid and Toxoplasmosis
| Article | Year |
|---|---|
[Streptococcus angina, myocarditis and toxoplasmosis following splenectomy].
Topics: Accidents, Traffic; Administration, Oral; Adult; Antistreptolysin; Biopsy; Complement Fixation Tests | 1970 |